Skip to content
Riskpilot
← Back to search
Sign in
Get full access
ALGIPHARMA AS
AS
Active
Org 964911444
Industriveien 33, 1337
Sandvika
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 1992 · 34 years old
6 employees
Monitor
Share
Norway
/
Companies
/
Research and experimental development on natural sciences and engineering
/
ALGIPHARMA AS
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (1)
YP
Yngvar Peter Berg
Chief Executive Officer
Chief Executive Officer
2012
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
DB
Diderik Børsting Schnitler
Board of Directors
Board of Directors
2020
AD
Arne Dessen
Chairman
Chairman
2020
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Algipharma Holding As
Company
100%
100%
2025
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on ALGIPHARMA AS
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network